Regulatory T cells in kidney allograft infiltrates correlate with initial inflammation and graft function

Transplantation

Volumn 89, Issue 2, 2010, Pages 194-199

  Taflin, Cécile ^a   Nochy, Dominique ^b   Hill, Gary ^b   Frouget, Thierry ^c   Rioux, Nathalie ^c   Vérine, Jérome ^b   Bruneval, Patrick ^b   Glotz, Denis ^a,b  

^a INSERM   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Hô Pital Pontchaillou ^*  (France)

Author keywords

Biopsy; FoxP3; Kidney allograft infiltrates; Regulatory T cells; Suppression

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CD20 ANTIGEN; CD68 ANTIGEN; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE;

ANTIGENS, CD; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; INFLAMMATION; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 76649106437     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c3ca11     Document Type: Article

References (29)

1. Benjamin RJ, Waldmann H. Induction of tolerance by monoclonal antibody therapy. Nature 1986; 320: 449.
2. Qin SX, Cobbold S, Benjamin R, et al. Induction of classical transplantation tolerance in the adult. J Exp Med 1989; 169: 779.
3. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151.
4. high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245.
5. +CD25~ T cells. J Clin Invest 2003; 112: 1437.
6. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531.
7. Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell2008; 133: 775.
8. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
9. Taylor PA, Noelle RJ, Blazar BR. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311.
10. + regulatory T cells prevent graft rejection: CTLA-4-and IL-10-dependent immuno-regulation of alloresponses. J Immunol 2002; 168: 1080.
11. Dijke IE, Weimar W, Baan CC. Regulatory T cells after organ transplantation: Where does their action take place? Hum Immunol 2008; 69:389.
12. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. NEngl JMed 2005; 353: 2342.
13. + cells in renal allografts during acute rejection. Am J Transplant 2007; 7: 914.
14. Bunnag S, Allanach K, Jhangri GS, et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 2008; 8:1423.
15. Grimbert P, Mansour H, Desvaux D, et al. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplantation 2007; 83: 341.
16. Mansour H, Homs S, Desvaux D, et al. Intragraft levels of Foxp3 mRNA predict progression in renal transplants with borderline change. J Am Soc Nephrol 2008; 19:2277.
17. + regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008; 19:2020.
18. + T cells. Eur J Im-munol2007; 37: 129.
19. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4(+) T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899.
20. + regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am J Pathol 2009; 174: 497.
21. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
22. Mengel M, Sis B, Halloran PF. SWOT analysis of Banff: Strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant 2007; 7: 2221.
23. Mueller TF, Einecke G, Reeve J, et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7: 2712.
24. Hoffmann SC, Hale DA, Kleiner DE, et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005; 5: 573.
25. Carvalho-Gaspar M, Jones ND, Luo S, et al. Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells. J Immunol 2008; 180:6640.
26. Ahmed R, Gray D. Immunological memory and protective immunity: Understanding their relation. Science 1996; 272: 54.
27. Swanson BJ, Murakami M, Mitchell TC, et al. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 2002; 17: 605.
28. Le Moine A, Goldman M, Abramowicz D. Multiple pathways to allograft rejection. Transplantation 2002; 73: 1373.
29. Brown K, Wong W. Diagnostic value of regulatory T cells: A new facet of a much studied cell population. Transplantation 2008; 86: 1485.